The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholler, N.
Right arrow Articles by Ledbetter, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholler, N.
Right arrow Articles by Ledbetter, J. A.
The Journal of Immunology, 2001, 166: 3865-3872.
Copyright © 2001 by The American Association of Immunologists

CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells1

Nathalie Scholler2,*, Martha Hayden-Ledbetter{dagger}, Karl-Erik Hellström*, Ingegerd Hellström* and Jeffrey A. Ledbetter{dagger}

Laboratories of * Tumor Immunology and {dagger} Immunobiology, Pacific Northwest Research Institute, Seattle, WA 98122

To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region (CD83Ig) and expressed by stable transfection of Chinese hamster ovary cells. Purified CD83Ig bound to peripheral blood monocytes and a subset of activated CD3+CD8+ lymphocytes but did not bind to FcR. Monocytes that had adhered to plastic lost their ability to bind to CD83Ig after 90 min of in vitro incubation. CD83Ig bound to two of five T cell lines tested, HPB-ALL and Jurkat. The binding to HPB-ALL cells significantly increased when they were grown at a low pH (pH 6.5), whereas binding to Jurkat cells increased after apoptosis was induced with anti-Fas mAb. B cell and monocytic lines did not bind CD83Ig and neither did CD56+ NK cells or granulocytes. Full-length CD83 expressed by a transfected carcinoma line mediated CD83-dependent adhesion to HPB-ALL cells. CD83Ig immunoprecipitated and immunoblotted a 72-kDa protein from HPB-ALL cells. Binding of CD83Ig to HPB-ALL cells was eliminated by neuraminidase treatment of the cells. We conclude that CD83 is an adhesion receptor with a counterreceptor expressed on monocytes and a subset of activated or stressed T lymphocytes, and that interaction between CD83 and its counterreceptor is dependent upon the state of glycosylation of a 72-kDa counterreceptor by sialic acid residues. In view of the selectivity of the expression of CD83 and its ligand, we postulate that the interaction between the two plays an important role in the induction and regulation of immune responses.




This article has been cited by other articles:


Home page
 BloodHome page
W. K. Decker, D. Xing, S. Li, S. N. Robinson, H. Yang, D. Steiner, K. V. Komanduri, and E. J. Shpall
Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens
Blood, April 30, 2009; 113(18): 4213 - 4223.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Luthje, B. Kretschmer, B. Fleischer, and M. Breloer
CD83 regulates splenic B cell maturation and peripheral B cell homeostasis
Int. Immunol., August 1, 2008; 20(8): 949 - 960.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Prazma, N. Yazawa, Y. Fujimoto, M. Fujimoto, and T. F. Tedder
CD83 Expression Is a Sensitive Marker of Activation Required for B Cell and CD4+ T Cell Longevity In Vivo
J. Immunol., October 1, 2007; 179(7): 4550 - 4562.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Kuwano, C. M. Prazma, N. Yazawa, R. Watanabe, N. Ishiura, A. Kumanogoh, H. Okochi, K. Tamaki, M. Fujimoto, and T. F. Tedder
CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
Int. Immunol., August 1, 2007; 19(8): 977 - 992.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. T. Prechtel, N. M. Turza, A. A. Theodoridis, and A. Steinkasserer
CD83 Knockdown in Monocyte-Derived Dendritic Cells by Small Interfering RNA Leads to a Diminished T Cell Stimulation
J. Immunol., May 1, 2007; 178(9): 5454 - 5464.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Ding, H. Mehta, W. J. McCune, and M. J. Kaplan
Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus
J. Immunol., November 1, 2006; 177(9): 5878 - 5889.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Hirano, M. O. Butler, Z. Xia, S. Ansen, M. S. von Bergwelt-Baildon, D. Neuberg, G. J. Freeman, and L. M. Nadler
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity
Blood, February 15, 2006; 107(4): 1528 - 1536.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Rughetti, I. Pellicciotta, M. Biffoni, M. Backstrom, T. Link, E. P. Bennet, H. Clausen, T. Noll, G. C. Hansson, J. M. Burchell, et al.
Recombinant Tumor-Associated MUC1 Glycoprotein Impairs the Differentiation and Function of Dendritic Cells
J. Immunol., June 15, 2005; 174(12): 7764 - 7772.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
E. Klein, S. Koch, B. Borm, J. Neumann, V. Herzog, N. Koch, and T. Bieber
CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells
Int. Immunol., April 1, 2005; 17(4): 477 - 487.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Ohta, E. Landis, T. Boulay, R. B. Phillips, B. Collet, C. J. Secombes, M. F. Flajnik, and J. D. Hansen
Homologs of CD83 from Elasmobranch and Teleost Fish
J. Immunol., October 1, 2004; 173(7): 4553 - 4560.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. F. Garcia-Martinez, M. W. Appleby, K. Staehling-Hampton, D. M. Andrews, Y. Chen, M. McEuen, P. Tang, R. L. Rhinehart, S. Proll, B. Paeper, et al.
A Novel Mutation in CD83 Results in the Development of a Unique Population of CD4+ T Cells
J. Immunol., September 1, 2004; 173(5): 2995 - 3001.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. L. Price, P. S. Sharp, M. E. North, S. J. Rainbow, and S. C. Knight
Advanced Glycation End Products Modulate the Maturation and Function of Peripheral Blood Dendritic Cells
Diabetes, June 1, 2004; 53(6): 1452 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Senechal, A. M. Boruchov, J. L. Reagan, D. N. J. Hart, and J. W. Young
Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83
Blood, June 1, 2004; 103(11): 4207 - 4215.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Yang, Y. Yang, J. Raycraft, H. Zhang, S. Kanan, Y. Guo, Z. Ronai, I. Hellstrom, and K. E. Hellstrom
Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137
PNAS, April 6, 2004; 101(14): 4990 - 4995.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
D. J. Munster, K. P. A. MacDonald, M. Kato, and D. J. N. Hart
Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity
Int. Immunol., January 1, 2004; 16(1): 33 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I. Schmitz, L. K. Clayton, and E. L. Reinherz
Gene expression analysis of thymocyte selection in vivo
Int. Immunol., October 1, 2003; 15(10): 1237 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Hinz, P. Lemke, I. Anagnostopoulos, C. Hacker, D. Krappmann, S. Mathas, B. Dorken, M. Zenke, H. Stein, and C. Scheidereit
Nuclear Factor {kappa}B-dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity
J. Exp. Med., September 2, 2002; 196(5): 605 - 617.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. I. Zimmer, A. T. Larregina, C. M. Castillo, S. Capuano III, L. D. Falo Jr, M. Murphey-Corb, T. A. Reinhart, and S. M. Barratt-Boyes
Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS
Blood, April 15, 2002; 99(8): 2859 - 2868.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Scholler, M. Hayden-Ledbetter, A. Dahlin, I. Hellstrom, K. E. Hellstrom, and J. A. Ledbetter
Cutting Edge: CD83 Regulates the Development of Cellular Immunity
J. Immunol., March 15, 2002; 168(6): 2599 - 2602.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Arrode, C. Boccaccio, J.-P. Abastado, and C. Davrinche
Cross-Presentation of Human Cytomegalovirus pp65 (UL83) to CD8+ T Cells Is Regulated by Virus-Induced, Soluble-Mediator-Dependent Maturation of Dendritic Cells
J. Virol., January 1, 2002; 76(1): 142 - 150.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.